Skip to content
drillr.ai
Sign up

DARE

Dare Bioscience, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.72
+1.11%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.4M1.0M9.8K2.8M10.0M
Cost of Revenue2.6M2.4M14.3M21.6M30.1M
Gross Profit(1.2M)(1.4M)(14.3M)(18.8M)(20.1M)
Operating Expenses
R&D Expense2.2M5.5B14.2M21.5M30.0M
SG&A Expense8.9M8.8M9.2M11.9M11.2M
General & Admin Expense8.7M8.8M8.4M11.3M10.6M
Selling & Marketing Expense202.0K—800.0K600.0K600.0K
Other Expenses(1.2M)(5.5B)(14.2M)(21.3M)(30.0M)
Total Operating Expenses9.9M12.1M9.2M12.1M11.2M
Cost and Expenses12.5M14.6M23.5M33.7M41.4M
Operating Income (EBIT)(11.1M)(13.6M)(23.5M)(30.9M)(31.4M)
Non-Operating
Interest Income191.7K679.7K———
Interest Expense199.4K822.7K———
Net Interest Income(7.7K)(143.0K)———
Other Non-Op Income/Expense123.1K153.1K19.4M778.5K437.8K
Non-Operating Income (excl Interest)(352.1K)(975.8K)(19.4M)(200.0K)(437.8K)
EBT (Pre-Tax Income)(11.0M)(13.4M)(4.1M)(30.2M)(30.9M)
Income Tax Expense—————
Bottom Line
Net Income(11.0M)(13.4M)(4.1M)(30.2M)(30.9M)
Earnings from Cont. Ops(11.0M)(13.4M)(4.1M)(30.2M)(30.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(11.0M)(13.4M)(4.1M)(30.2M)(30.9M)
Per Share
Basic EPS($0.79)($1.20)($0.48)($4.15)($4.39)
Diluted EPS($0.79)($1.20)($0.48)($4.15)($4.39)
Revenue Per Share$0.09$0.01$0.00$0.39$1.42
Shares
Basic Shares Outstanding14.9M111.8M8.5M7.3M7.0M
Diluted Shares Outstanding14.9M111.8M8.5M7.3M7.0M
Profitability Metrics
EBITDA(9.2M)(10.4M)(4.0M)(30.7M)(30.9M)
D&A1.6M2.2M42.3K38.4K24.2K
EBIT(10.8M)(12.6M)(4.1M)(30.7M)(30.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026